About Korio
Korio is a company based in San Francisco (United States) founded in 2021 by Chuck Harris and Ryan Keane.. Korio has raised $12.3 million across 2 funding rounds from investors including BIP Ventures, Excelerate Health Ventures and Boston Millennia Partners. Korio operates in a competitive market with competitors including N-SIDE, Endpoint Clinical, Mosiac InVivo, Nomeco CTSM and Clinapps, among others.
- Headquarter San Francisco, United States
- Founders Chuck Harris, Ryan Keane
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$12.3 M (USD)
in 2 rounds
-
Latest Funding Round
$5.5 M (USD), Series A
Aug 23, 2024
-
Investors
BIP Ventures
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Korio
Korio has successfully raised a total of $12.3M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $5.5 million completed in August 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $5.5M
-
First Round
First Round
(10 Oct 2023)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2024 | Amount | Series A - Korio | Valuation | BIP Ventures | |
| Oct, 2023 | Amount | Seed - Korio | Valuation | Excelerate Health Ventures |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Korio
Korio has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include BIP Ventures, Excelerate Health Ventures and Boston Millennia Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are provided by BIP Ventures.
|
Founded Year | Domain | Location | |
|
Venture capital is provided for AI-driven healthcare innovations.
|
Founded Year | Domain | Location | |
|
US-focused private equity and venture capital investments are managed.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Korio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Korio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Korio Comparisons
Competitors of Korio
Korio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as N-SIDE, Endpoint Clinical, Mosiac InVivo, Nomeco CTSM and Clinapps, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cloud and AI-based analytics are offered for supply chain optimization.
|
|
| domain | founded_year | HQ Location |
Interactive Response Technology systems are provided for clinical trials.
|
|
| domain | founded_year | HQ Location |
Software solutions for pre-clinical scientific data management in life sciences.
|
|
| domain | founded_year | HQ Location |
Delivers comprehensive solutions for clinical trial supply management.
|
|
| domain | founded_year | HQ Location |
Software products and services for the pharmaceutical and biotechnology industries
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Korio
Frequently Asked Questions about Korio
When was Korio founded?
Korio was founded in 2021 and raised its 1st funding round 2 years after it was founded.
Where is Korio located?
Korio is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Who is the current CEO of Korio?
Ryan Keane is the current CEO of Korio. They have also founded this company.
Is Korio a funded company?
Korio is a funded company, having raised a total of $12.3M across 2 funding rounds to date. The company's 1st funding round was a Seed of $6.8M, raised on Oct 10, 2023.
What does Korio do?
Korio was founded in 2021 in San Francisco, United States, as a provider in the health technology sector. An IRT platform is offered by the company for clinical trial randomization, supply management, and design. Operations focus on supporting pharmaceutical and biotech firms with tools for efficient trial logistics. The domain korioclinical.com is used for its online presence. Co-founders include Chuck Harris and Ryan Keane, with Keane serving as CEO.
Who are the top competitors of Korio?
Korio's top competitors include Endpoint Clinical, N-SIDE and Clinapps.
Who are Korio's investors?
Korio has 3 investors. Key investors include BIP Ventures, Excelerate Health Ventures, and Boston Millennia Partners.